Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 3)

v3.23.2
STOCKHOLDERS EQUITY (DEFICIT) (Details 3) - Registered Warrant - 5.50
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Exercise price range 5.50
Number of exercisable Register warrant 2,975,497
Number of exercisable options 2,975,497
Weighted average exercise price exercisable term 2 years 11 months 4 days
Exercise price Exercisable range 5.50
Weighted average exercise price exercisable | $ / shares $ 5.50